NEWS
Making it easy for our investors to stay current with our portfolio companies and their industries.
October 30, 2025
Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
September 24, 2025
A New Epoch in Hyperscale Data Mastery: Ocient’s Relentless Pursuit of Transformational Value
September 22, 2025
Virtual screens could make augmented reality more useful during cardiac ablation
September 16, 2025
How and why the Tri-Valley became a great place for life sciences innovation
September 16, 2025
Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO